Yee et al.have subsequently demonstrated complete regression of metastatic melanoma upon infusion ofcloned CD4+ T-cells directed against NY-ESO-1, suggesting that CD4+ T-cells can potentiallymediate direct effector function in addition to providing help to effector CD8+ T-cells [15]. Here, CD4 is linked to metastatic melanoma.